RXRX
Price
$5.27
Change
+$0.06 (+1.15%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
2.14B
40 days until earnings call
TLPPF
Price
$15.66
Change
-$0.34 (-2.12%)
Updated
Jul 2 closing price
Capitalization
5.45B
Interact to see
Advertisement

RXRX vs TLPPF

Header iconRXRX vs TLPPF Comparison
Open Charts RXRX vs TLPPFBanner chart's image
Recursion Pharmaceuticals
Price$5.27
Change+$0.06 (+1.15%)
Volume$265.47K
Capitalization2.14B
Telix Pharmaceutical
Price$15.66
Change-$0.34 (-2.12%)
Volume$26.15K
Capitalization5.45B
RXRX vs TLPPF Comparison Chart in %
Loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RXRX vs. TLPPF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXRX is a Buy and TLPPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (RXRX: $5.21 vs. TLPPF: $15.66)
Brand notoriety: RXRX and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RXRX: 98% vs. TLPPF: 642%
Market capitalization -- RXRX: $2.14B vs. TLPPF: $5.45B
RXRX [@Biotechnology] is valued at $2.14B. TLPPF’s [@Biotechnology] market capitalization is $5.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXRX’s FA Score shows that 0 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • RXRX’s FA Score: 0 green, 5 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, both RXRX and TLPPF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 5 TA indicator(s) are bullish while TLPPF’s TA Score has 2 bullish TA indicator(s).

  • RXRX’s TA Score: 5 bullish, 3 bearish.
  • TLPPF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than TLPPF.

Price Growth

RXRX (@Biotechnology) experienced а +0.97% price change this week, while TLPPF (@Biotechnology) price change was -0.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLPPF($5.45B) has a higher market cap than RXRX($2.14B). TLPPF YTD gains are higher at: 4.608 vs. RXRX (-22.929). TLPPF has higher annual earnings (EBITDA): 92.5M vs. RXRX (-524.77M). TLPPF has more cash in the bank: 710M vs. RXRX (500M). RXRX has less debt than TLPPF: RXRX (92.9M) vs TLPPF (581M). TLPPF has higher revenues than RXRX: TLPPF (783M) vs RXRX (59.8M).
RXRXTLPPFRXRX / TLPPF
Capitalization2.14B5.45B39%
EBITDA-524.77M92.5M-567%
Gain YTD-22.9294.608-498%
P/E RatioN/A164.75-
Revenue59.8M783M8%
Total Cash500M710M70%
Total Debt92.9M581M16%
FUNDAMENTALS RATINGS
TLPPF: Fundamental Ratings
TLPPF
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
17
SMR RATING
1..100
73
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RXRXTLPPF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
63%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PNGAX16.15N/A
N/A
Putnam International Value A
MIGKX44.23N/A
N/A
MFS Massachusetts Inv Gr Stk R4
KCGIX22.10N/A
N/A
Knights of Columbus Large Cap Growth I
PGELX27.17N/A
N/A
George Putnam Balanced R5
NGJAX18.97N/A
N/A
Nuveen Global Real Estate Securities A

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and GLMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and GLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
-2.09%
GLMD - TLPPF
25%
Poorly correlated
-2.17%
DNLI - TLPPF
24%
Poorly correlated
+6.81%
BEAM - TLPPF
24%
Poorly correlated
+13.46%
RXRX - TLPPF
23%
Poorly correlated
+1.56%
JANX - TLPPF
23%
Poorly correlated
+3.62%
More